文献速递慢性静脉疾病

使用氰基丙烯酸酯胶(VenaSeal™)腔内闭合大隐静脉、小隐静脉及前副静脉治疗症状性静脉曲张的真实世界安全性与效率:单术者多中心回顾性研究

Real-World Safety and Efficiency of Treating Symptomatic Varicose Veins with Endovenous Closure of Great, Small, and Anterior Accessory Veins Using Cyanoacrylate Glue (VenaSeal™): A Single-surgeon Multicenter Retrospective Study.
PubMed 文献 · Ann Vasc Surg · 2024-12-12

这项单术者多中心回顾性研究纳入2018年12月至2022年8月期间480例患者(712条腿)的804条功能不全隐静脉,采用VenaSeal系统行氰基丙烯酸酯腔内闭合,曲张属支行超声引导泡沫硬化剂治疗。首次随访(72小时内)闭合率99.6%(791/794),第二次(4个月)99.3%(731/736),第三次(16个月)97.2%(520/535)。结论认为氰基丙烯酸酯腔内闭合是治疗隐静脉功能不全有效且安全的方法。

要点

  • 16个月超声闭合率为97.2%(520/535)。
  • 无临床有症状或闭塞性深静脉血栓,无胶致静脉血栓。
  • 30例膝下非闭塞性深静脉血栓与泡沫硬化剂治疗相关,8例胶血栓延伸,均经抗凝治疗并在3个月内消退。

核心结论

  • 真实世界研究显示氰基丙烯酸酯腔内闭合是治疗隐静脉功能不全有效且安全的方法。

研究设计与样本

  • 回顾性、单术者、多中心研究,报告使用VenaSeal系统行氰基丙烯酸酯腔内闭合治疗静脉曲张的结局,曲张属支行超声引导泡沫硬化剂治疗。
  • 共纳入480例患者(712条腿)的804条功能不全隐静脉,治疗时间为2018年12月至2022年8月。
  • 随访时点为72小时内、4个月和16个月,行双功超声检查。

主要发现

  • 首次随访超声闭合率为99.6%(791/794),第二次随访为99.3%(731/736),第三次随访为97.2%(520/535)。
  • 所有随访期间,临床有症状或闭塞性深静脉血栓为0例,胶致静脉血栓为0例。
  • 偶然发现30例与泡沫硬化剂治疗相关的膝下非闭塞性深静脉血栓,以及8例胶血栓延伸,均经抗凝治疗成功并在3个月内消退。
  • 无闭塞性或膝上深静脉血栓、相关肺栓塞、出血事件、死亡或需住院的并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment of symptomatic varicose veins has changed dramatically in the last few years with guidelines now recommending endovenous surgery as first-line intervention. Previously, this was achieved by laser or radiofrequency ablation of the target vein, requiring infiltration of tumescent anesthesia to reduce the risks of thermal damage to surrounding tissue. Endovenous cyanoacrylate injection (VenaSeal™) is a nonthermal, nontumescent endovenous closure technique, increasing patient comfort and is readily performed under local anesthesia only and thus is a feasible technique for in-room treatment. The aim of this study was to investigate the 16 month closure rates and safety of the VenaSeal system for the treatment of lower limb varicose vein surgery. METHODS: This is a retrospective, single-surgeon, multicenter study reporting outcomes for the treatment of varicose veins using endovenous closure with cyanoacrylate closure (CAC) using the VenaSeal system. Varicose tributary treatment was performed with ultrasound-guided foam sclerotherapy. Patients were followed up with duplex ultrasound within 72 hours, 4 months, and 16 months. The primary outcome of the study was the successful closure of the target vein. Secondary outcomes were complications including deep venous thrombosis (DVT), pulmonary embolism (PE), bleeding, admission, and mortality. RESULTS: Briefly, 804 incompetent saphenous veins in 480 patients (712 legs) underwent CAC between December 2018 and August 2022. The sonographic closure rate was 99.6% (791/794) at first follow-up, 99.3% (731/736) at second follow-up, and 97.2% (520/535) at third follow-up. Secondary outcomes across all follow-ups included 0 clinically symptomatic or occlusive DVTs, or endovenous glue-induced thrombosis. Incidentally, there were 30 nonocclusive below-knee DVTs related to foam sclerotherapy, and 8 glue thrombus extension, all of which were successfully treated with anticoagulation and resolved by 3 months. There were no occlusive or above knee DVTs, related PEs, bleeding events, deaths, or complications requiring admission. CONCLUSIONS: Our real-world study illustrates that CAC is an effective and safe method for treating saphenous incompetence.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lu PYJ, Fung CHC, Brooks C, et al. Real-World Safety and Efficiency of Treating Symptomatic Varicose Veins with Endovenous Closure of Great, Small, and Anterior Accessory Veins Using Cyanoacrylate Glue (VenaSeal™): A Single-surgeon Multicenter Retrospective Study. Ann Vasc Surg. 2024. PMID: 39672268. doi:10.1016/j.avsg.2024.11.101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。